Emergency and Critical Care Center, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vascular Disease, Beijing, 100029, China.
Emergency and Critical Care Center, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vascular Disease, Beijing, 100029, China.
Chin J Traumatol. 2022 Mar;25(2):67-76. doi: 10.1016/j.cjtee.2021.08.003. Epub 2021 Aug 5.
Trauma-induced pulmonary thromboembolism is the second leading cause of death in severe trauma patients. Primary fibrinolytic hyperactivity combined with hemorrhage and consequential hypercoagulability in severe trauma patients create a huge challenge for clinicians. It is crucial to ensure a safe anticoagulant therapy for trauma patients, but a series of clinical issues need to be answered first, for example, what are the risk factors for traumatic venous thromboembolism? How to assess and determine the status of coagulation dysfunction of patients? When is the optimal timing to initiate pharmacologic prophylaxis for venous thromboembolism? What types of prophylactic agents should be used? How to manage the anticoagulation-related hemorrhage and to determine the optimal timing of restarting chemoprophylaxis? The present review attempts to answer the above questions.
创伤性肺血栓栓塞症是严重创伤患者死亡的第二大主要原因。严重创伤患者的原发性纤维蛋白溶解活性亢进、出血和继发的高凝状态给临床医生带来了巨大的挑战。为创伤患者提供安全的抗凝治疗至关重要,但首先需要回答一系列临床问题,例如,创伤性静脉血栓栓塞的危险因素有哪些?如何评估和确定患者凝血功能障碍的状态?启动药物预防静脉血栓栓塞的最佳时机是什么时候?应该使用哪些预防性药物?如何处理抗凝相关出血以及确定重新开始化学预防的最佳时机?本综述试图回答上述问题。